Alzheimer’s Disease

The benefits of GWAS in understanding Alzheimer’s disease

Therapeutic development in Alzheimer’s disease and the lack of funding

Cross neurodegenerative disease genetic analysis: similarities and differences

Identifying new therapeutic targets for neurodegenerative diseases

The future of Alzheimer’s disease: aducanumab

Hopeful developments for Alzheimer’s Disease

Defining Alzheimer’s disease: clinical or biological

CT1812: exciting preliminary results

Therapeutics designed to mimic protective mutations for Alzheimer’s disease

A673T mutation lowers Aβ oligomer binding affinity: Alzheimer’s disease protective mechanism

Atypical presentation of Alzheimer’s disease in younger patients

The use of digital memory notebooks to improve memory impairment

Is technology the way forward in geriatric diagnosis?

Biomarker blood tests as diagnostic tool for Alzheimer’s disease

Can we predict the onset of Alzheimer’s disease using blood tests?

Representative population for Alzheimer’s disease research